Literature DB >> 3453385

Clinical validation of the accutracker, a novel ambulatory blood pressure monitor using R-wave gating for Korotkoff sounds.

W B White1, P Schulman, E J McCabe, M B Nardone.   

Abstract

We compared simultaneous, same-arm blood pressure (BPs) obtained with the Accutracker, an ambulatory blood pressure (BP) monitor, which uses R-wave gating for Korotkoff sounds to those of both a blinded, skilled clinician using a mercury column and a three-channel graphic display of cuff pressure tracings, Korotkoff sounds, and ECG tracing. Eighteen subjects, with a wide variety of BPs, heart rates, and ages, participated in the study. The systolic BP obtained by the ambulatory recorder, clinician, and the three-channel strip chart recorder were 132 +/- 23 mmHg, 132 +/- 24 mmHg, and 133 +/- 25 mmHg, (all NS), respectively. Accutracker recorder-determined systolic BP correlated highly both with the clinician and strip chart readings (r = 0.98 and 0.97, respectively; p less than 0.0001 for both). The diastolic BP obtained by the Accutracker recorder was slightly, but significantly, lower than the clinician's readings (76 +/- 12 mmHg vs. 81 +/- 13 mmHg; p less than 0.005) and similar to the strip chart recorder readings (76 +/- 12 mmHg vs. 77 +/- 12 mmHg; NS). In 32 young, healthy subjects with no activity restrictions, 91% of the raw BP data from 24-hour ambulatory recordings was acceptable using strict deletion criteria. These data demonstrate that the Accutracker is highly accurate compared with clinician-determined blood pressures. The lower diastolic BP readings may stem from the ability of this device to detect softer Korotkoff sounds than can be detected by the clinician. These findings should be taken into consideration when using ambulatory BP monitoring in clinical trials of antihypertensive drugs.

Entities:  

Mesh:

Year:  1987        PMID: 3453385

Source DB:  PubMed          Journal:  J Clin Hypertens        ISSN: 0748-450X            Impact factor:   3.738


  4 in total

1.  Neurocognition in treatment-resistant hypertension: profile and associations with cardiovascular biomarkers.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

2.  Effects of exercise and stress management training on nighttime blood pressure dipping in patients with coronary heart disease: A randomized, controlled trial.

Authors:  Andrew Sherwood; Patrick J Smith; Alan L Hinderliter; Anastasia Georgiades; James A Blumenthal
Journal:  Am Heart J       Date:  2016-10-20       Impact factor: 4.749

3.  Statistical evaluation of circadian blood pressure rhythm during isradipine long-term therapy.

Authors:  F Veglio; F Rabbia; R Melchio; L Chiandussi
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring.

Authors:  C A Silagy; J J McNeil; S Farish; B P McGrath
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.